American drug discovery consultancy founded by the medicinal chemist Francesco G. Salituro, who worked at Merrell Dow, Vertex Pharmaceuticals, Wyeth Research and Agios before leading chemistry at Sage Therapeutics. Advises pharmaceutical and biotechnology companies on medicinal chemistry strategy, lead optimisation and candidate selection across therapeutic areas, drawing on work that produced clinical candidates and marketed medicines including brexanolone, ivosidenib and enasidenib.
コメントはありません。
評価とコメントを残す